Mutations in parkin are largely associated with autosomal recessive juvenile parkinsonism (AR-JP). The underlying mechanism of pathogenesis in parkin-associated Parkinson's disease (PD) is thought to be due to the loss of parkin's E3 ubiquitin ligase activity leading to accumulation of parkin substrates due to failure of the ubiquitin proteasome system. A large number of possible parkin substrates have been identified, yet their role in the pathogenesis of PD due to parkin mutations have yet to be clarified. Moreover, the post-translational modifications that potentially regulate parkin's function are not known. We propose to generate and characterize parkin knockout mice to test the role of proteasome dysfunction in PD. Furthermore, we propose to characterize and identify parkin substrates, and identify potential post-translational modifications of parkin that regulate its function, thus providing important new information about the role of UPS dysfunction in PD. To accomplish these goals we propose the following specific aims.
In Specific Aim #1 we will generate and characterize parkin knockout mice.
In Specific Aim #2 we will evaluate the sensitivity of parkin knockouts to proteasome inhibitors.
In Specific Aim #3 we will characterize the Role of Nitrosative Stress on Parkin Function.
In Specific Aim #4 we will identify additional and potentially authentic parkin substrates in parkin knockout mice in response to proteasome inhibition. Identification and characterization of parkin substrates and regulatory mechanisms of parkin function may provide novel therapeutics and targets to prevent the toxic effects of this familial associated gene in the degenerative process of PD.
| Lee, Byoung Dae; Li, Xiaojie; Dawson, Ted M et al. (2012) Measuring the activity of leucine-rich repeat kinase 2: a kinase involved in Parkinson's disease. Methods Mol Biol 795:45-54 |
| Dawson, Ted M; Dawson, Valina L (2011) A lysosomal lair for a pathogenic protein pair. Sci Transl Med 3:91ps28 |
| Shin, Joo-Ho; Ko, Han Seok; Kang, Hochul et al. (2011) PARIS (ZNF746) repression of PGC-1? contributes to neurodegeneration in Parkinson's disease. Cell 144:689-702 |
| Martin, Ian; Dawson, Valina L; Dawson, Ted M (2011) Recent advances in the genetics of Parkinson's disease. Annu Rev Genomics Hum Genet 12:301-25 |
| Dawson, Ted M; Ko, Han Seok; Dawson, Valina L (2010) Genetic animal models of Parkinson's disease. Neuron 66:646-61 |
| Vives-Bauza, Cristofol; Zhou, Chun; Huang, Yong et al. (2010) PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci U S A 107:378-83 |
| Ko, Han Seok; Lee, Yunjong; Shin, Joo-Ho et al. (2010) Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function. Proc Natl Acad Sci U S A 107:16691-6 |
| Ko, Han Seok; Bailey, Rachel; Smith, Wanli W et al. (2009) CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity. Proc Natl Acad Sci U S A 106:2897-902 |
| Tan, Jeanne M M; Wong, Esther S P; Kirkpatrick, Donald S et al. (2008) Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases. Hum Mol Genet 17:431-9 |
| Habib, Samy L; Michel, David; Masliah, Eliezer et al. (2008) Role of tuberin in neuronal degeneration. Neurochem Res 33:1113-6 |
Showing the most recent 10 out of 28 publications
